<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04106583</url>
  </required_header>
  <id_info>
    <org_study_id>CLP 13669</org_study_id>
    <nct_id>NCT04106583</nct_id>
  </id_info>
  <brief_title>Assessing the WAVE Extra Soft Coil in Intracranial Aneurysms and Comparing Imaging Modalities</brief_title>
  <acronym>SURF</acronym>
  <official_title>A Prospective, Multicenter Study Assessing the Embolization of Intracranial Aneurysms Using WAVE™ Extra Soft Coils, a Part of the Penumbra SMART COIL® System</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Penumbra Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Penumbra Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to demonstrate the safety and efficacy of the Penumbra SMART
      COIL® System, including the WAVE™ Extra Soft Coils (WAVE) as a fill and finish coil, in the
      treatment of intracranial aneurysms. Imaging will be analyzed by an independent core lab to
      assess aneurysm occlusion rates and perform a comparative analysis between imaging
      modalities.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 30, 2019</start_date>
  <completion_date type="Anticipated">June 2023</completion_date>
  <primary_completion_date type="Anticipated">June 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Efficacy: Adequate Occlusion</measure>
    <time_frame>Through Study Completion, An Average of 1 Year</time_frame>
    <description>Adequate occlusion defined as Raymond-Roy Class I and II at final follow-up
Raymond-Roy Class grading ranges I to III higher values represent a worse outcome.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Safety: Serious Adverse Events (SAEs)</measure>
    <time_frame>Up to 24 Hours Post-Procedure</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Safety: Device-Related SAE</measure>
    <time_frame>Through Discharge, up to 7 Days Post-Procedure</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Efficacy: Occlusion rate</measure>
    <time_frame>Immediate Post-Procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Efficacy: Retreatment Rate</measure>
    <time_frame>Through Study Completion, An Average of 1 Year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Efficacy: Aneurysm Occlusion Raymond I</measure>
    <time_frame>Immediate Post-Treatment</time_frame>
    <description>Raymond-Roy Class grading ranges I to III higher values represent a worse outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Efficacy: Aneurysm Occlusion Raymond I</measure>
    <time_frame>Through Study Completion, An Average of 1 Year</time_frame>
    <description>Raymond-Roy Class grading ranges I to III higher values represent a worse outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Efficacy: Aneurysm Recanalization or Progressive Thrombosis</measure>
    <time_frame>From Immediate Post Procedure Through Study Completion, An Average of 1 Year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Safety: Major Ipsilateral Stroke</measure>
    <time_frame>Through Study Completion, An Average of 1 Year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Safety: Device-Related SAE</measure>
    <time_frame>Through Study Completion, An Average of 1 Year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Safety: All-cause Morbidity and Mortality</measure>
    <time_frame>Through Study Completion, An Average of 1 Year</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">800</enrollment>
  <condition>Aneurysm, Brain</condition>
  <arm_group>
    <arm_group_label>Single Arm</arm_group_label>
    <description>Single Arm - Patients with intracranial aneurysms treated with WAVE, as part of the Penumbra SMART COIL System</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>WAVE, as part of the SMART COIL System</intervention_name>
    <description>WAVE, as part of the SMART COIL System</description>
    <arm_group_label>Single Arm</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with intracranial aneurysms treated with WAVE, as part of the Penumbra SMART COIL
        System
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient age ≥ 18 years

          -  Patient having embolization of intracranial aneurysms

          -  WAVE Extra Soft Coil is final finishing coil

          -  Penumbra SMART COIL System accounts for at least 75% of total number of coils
             implanted

          -  Informed consent obtained per IRB/EC requirements

        Exclusion Criteria:

          -  Life expectancy less than 1 year

          -  Patient previously enrolled in the SURF Study

          -  Known multiple intracranial aneurysms requiring treatment during index procedure

          -  Patient is unwilling or unable to comply with protocol follow up schedule and/or based
             on the Investigator's judgment the patient is not a good study candidate

          -  Participation in an interventional drug or device study that may confound the results
             of the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Clemens M Schirmer, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Geisinger Clinic</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ravi Radhakrishnan</last_name>
    <phone>+1 404 519 7065</phone>
    <email>rradhakrishnan@penumbrainc.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Michaella Corso</last_name>
    <phone>+1 510 995 2079</phone>
    <email>mcorso@penumbrainc.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Los Robles</name>
      <address>
        <city>Thousand Oaks</city>
        <state>California</state>
        <zip>91360</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Muhammad Taqi, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>RIA</name>
      <address>
        <city>Englewood</city>
        <state>Colorado</state>
        <zip>80113</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ian Kaminsky, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>St. Anthony's Hospital</name>
      <address>
        <city>Lakewood</city>
        <state>Colorado</state>
        <zip>80228</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ted Larson, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Yale New Haven</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>06320</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Charles Matouk, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Jackson Memorial</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33136</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert Starke, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tampa General Hospital</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33606</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zeguang Ren, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Morton Plant</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33756</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eric Lopez, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ochsner Medical Center</name>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <zip>70121</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>James Milburn, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>SSM Health Care</name>
      <address>
        <city>Bridgeton</city>
        <state>Missouri</state>
        <zip>63044</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amer Al Shekhlee, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>North Shore University</name>
      <address>
        <city>Manhasset</city>
        <state>New York</state>
        <zip>11030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Henry Woo, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mount Sinai Hospital</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paul Singh, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Stony Brook University</name>
      <address>
        <city>Stony Brook</city>
        <state>New York</state>
        <zip>11794</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Fiorella, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Vidant Medical Center</name>
      <address>
        <city>Greenville</city>
        <state>North Carolina</state>
        <zip>27834</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Richard Dalyai, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mercy St. Vincent</name>
      <address>
        <city>Toledo</city>
        <state>Ohio</state>
        <zip>43608</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sam Zaidat, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Geisinger Medical Center</name>
      <address>
        <city>Danville</city>
        <state>Pennsylvania</state>
        <zip>17822</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christoph Griessenauer, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>MUSC</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29425</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kimberly Kicielinsky, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Greenville Memorial Hospital</name>
      <address>
        <city>Greenville</city>
        <state>South Carolina</state>
        <zip>29605</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Imran Chaudry, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Erlanger Baroness Hospital</name>
      <address>
        <city>Chattanooga</city>
        <state>Tennessee</state>
        <zip>37403</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Harris Hawk, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Tennessee Medical Center, Knoxville</name>
      <address>
        <city>Knoxville</city>
        <state>Tennessee</state>
        <zip>37996</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andy Nicholson, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Medical City Plano - TSI</name>
      <address>
        <city>Plano</city>
        <state>Texas</state>
        <zip>75075</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Albert Yoo, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Riverside Regional Medical Center</name>
      <address>
        <city>Newport News</city>
        <state>Virginia</state>
        <zip>23601</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pankaja Ramakrishnan, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>September 25, 2019</study_first_submitted>
  <study_first_submitted_qc>September 25, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 27, 2019</study_first_posted>
  <last_update_submitted>June 30, 2020</last_update_submitted>
  <last_update_submitted_qc>June 30, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 2, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Intracranial Aneurysm</mesh_term>
    <mesh_term>Aneurysm</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

